🔎 Trials Near Me

Почетна › Akutna mijeloidna leukemija › Kalifornija › Los Angeles

Kliničke studije za Akutna mijeloidna leukemija u gradu Los Angeles, CA

25 studija za Akutna mijeloidna leukemija traži učesnike na lokacijama u gradu Los Angeles i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

Тражи се учесникФаза 2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07304011

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Cedars-Sinai Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06317649

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Тражи се учесникФаза 3
  • Cedars-Sinai Medical Center, Los Angeles
  • USC Norris Cancer Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07007312

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Cedars-Sinai Medical Center, Los Angeles
Узраст од 18 до 59 · Оба пола · Ажурирано 9. 11. 2026. · NCT05554406

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 3
  • US-Los Angeles CA-UCLA, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 6. 11. 2026. · NCT07223814

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Тражи се учесникФаза 2
  • Cedars-Sinai Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 2. 11. 2026. · NCT05564390

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

Тражи се учесникФаза 3
  • University of California Los Angeles (UCLA) - David Geffen School of Medicine, Los Angeles
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT05429632

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Тражи се учесникФаза 1/2
  • UCLA, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT05143996

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Тражи се учесникФаза 2
  • Cedars-Sinai Medical Center, Los Angeles
Узраст од 18 до 59 · Оба пола · Ажурирано 28. 10. 2026. · NCT05554393

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Тражи се учесникФаза 2/3
  • Keck School of Medicine of USC, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT04256317

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Тражи се учесникФаза 3
  • Children's Hospital Los Angeles, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Mattel Children's Hospital UCLA, Los Angeles
6 Months – 21 Years · Оба пола · Ажурирано 17. 9. 2026. · NCT04293562

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

Тражи се учесникФаза 2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT06824168

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Тражи се учесникФаза 2
  • UCLA Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT04996875

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Тражи се учесникФаза 3
  • US-Los Angeles CA-UCLA, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06652438

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • Children's Hospital Los Angeles, Los Angeles
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • UCLA Health - Bowyer Oncology Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 20. 8. 2026. · NCT06001788

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Тражи се учесникФаза 2
  • UCLA Department of Medicine, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Тражи се учесникОпсервациона студија
  • UCLA, Los Angeles
Сви узрасти · Оба пола · Ажурирано 6. 7. 2026. · NCT01351545

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

Тражи се учесникОпсервациона студија
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT03921047

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Тражи се учесникФаза 1
  • USC / Norris Comprehensive Cancer Center, Los Angeles
  • UCLA - Bowyer Oncology Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 13. 3. 2026. · NCT05735184

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

Тражи се учесникФаза 1
  • University of California Los Angeles, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 24. 9. 2025. · NCT06501196

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Тражи се учесникФаза 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 26. 8. 2025. · NCT03850574

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

Тражи се учесникФаза 1
  • UCLA Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 10. 3. 2025. · NCT05190471

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Тражи се учесникФаза 2
  • UCLA Medical Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 7. 3. 2025. · NCT02781883

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

Тражи се учесникФаза 2
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Узраст 18 и старији · Оба пола · Ажурирано 29. 5. 2024. · NCT04905810

Studije za Akutna mijeloidna leukemija u drugim gradovima

Ostale studije u gradu Los Angeles

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.